4//SEC Filing
Dallas Matthew D 4
Accession 0000899243-18-002740
CIK 0001325879other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 7:57 PM ET
Size
5.4 KB
Accession
0000899243-18-002740
Insider Transaction Report
Form 4
Dallas Matthew D
VP, Finance
Transactions
- Award
Stock Option (right to buy)
2018-02-01+250,000→ 250,000 totalExercise: $3.08Exp: 2028-02-01→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in equal monthly installments from February 1, 2018, through February 1, 2022, subject to the Reporting Person's continued service to the Company.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeother
Related Parties
1- filerCIK 0001612396
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 7:57 PM ET
- Size
- 5.4 KB